drugset / Trial / NCT01954238
A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and Pharmacokinetics/Pharmacodynamics of multiple doses of GCC-4401C in healthy male subjects.
Timeline
- Start
- 2013-08
- Primary completion
- 2014-03
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | GCC-4401C | Small molecule | 10 mg | Oral |
| Comparator | GCC-4401C | Small molecule | 20 mg | Oral |
| Comparator | GCC-4401C | Small molecule | 40 mg | Oral |
| Comparator | GCC-4401C | Small molecule | 60 mg | Oral |
| Comparator | GCC-4401C | Small molecule | 80 mg | Oral |
| Subject | Rivaroxaban | Other / unclassified | 20 mg | Oral |
Indications
No indication recorded.